LEADER 01811nam  2200373   450 
001 9910674034703321
005 20230624110637.0
035   $a(CKB)5400000000043479
035   $a(NjHacI)995400000000043479
035   $a(EXLCZ)995400000000043479
100   $a20230624d2022      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 04$aThe Latest Clinical Advances in Thrombocytopenia /$fedited by Hugo ten Cate, Bernhard Lammle
210  1$a[Place of publication not identified] :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2022.
210  4$dİ2022
215   $a1 online resource (312 pages)
311   $a3-0365-2804-0 
320   $aIncludes bibliographical references and index.
330   $aPlatelets are critical elements in the blood stream, supporting hemostasis (defense against bleeding), as well as performing even more complex tasks within networks of biological (immunity) and pathophysiological processes, such as cancer and ischemia/reperfusion injury. Changes in the number (and function) of platelets may have a substantial impact on any of these processes. The "simple" finding of a reduced platelet count (thrombocytopenia) has a history (origin) and a consequence (e.g., bleeding). This book brings together international experts to provide an up-to-date overview of the impact of thrombocytopenia from a clinical perspective.
606   $aThrombocytopenia
615  0$aThrombocytopenia.
676   $a616.157
702   $aLammle$b Bernhard
702   $aCate$b Hugo ten
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910674034703321
996   $aThe Latest Clinical Advances in Thrombocytopenia$93393132
997   $aUNINA